uniQure N.V. Foreign Currency Exchange Rate, Translation
uniQure N.V. (QURE) had Foreign Currency Exchange Rate, Translation of 117.50% as of 2025-12-31, per its 10-K filed 2026-03-02.
Financial Statements › Notes
us-gaap:ForeignCurrencyExchangeRateTranslation1 · last filed 2026-03-02
- 2025-12-31: Foreign Currency Exchange Rate, Translation 117.50%.
- 2024-12-31: Foreign Currency Exchange Rate, Translation 104.00%.
- 2023-12-31: Foreign Currency Exchange Rate, Translation 110.00%.
- 2019-12-31: Foreign Currency Exchange Rate, Translation 112.00%.
pure
| Period end | Foreign Currency Exchange Rate, Translation |
|---|---|
| 2025-12-31 | 117.50% 10-K · filed 2026-03-02 |
| 2024-12-31 | 104.00% 10-K · filed 2025-02-27 |
| 2023-12-31 | 110.00% 10-K · filed 2024-02-28 |
| 2019-12-31 | 112.00% 10-K · filed 2020-03-02 |
| 2018-12-31 | 114.45% 10-K · filed 2019-02-28 |
| 2017-12-31 | 119.91% 10-K · filed 2018-03-14 |
| 2016-12-31 | 105.20% 10-K · filed 2017-03-15 |
USD/EUR
| Period end | Foreign Currency Exchange Rate, Translation | Foreign Currency Exchange Rate, Translation as first filed |
|---|---|---|
| 2025-12-31 | 1.18 USD/EUR 10-K · filed 2026-03-02 | |
| 2024-12-31 | 1.04 USD/EUR 10-K · filed 2025-02-27 | |
| 2023-12-31 | 1.10 USD/EUR 10-K · filed 2024-02-28 | |
| 2022-12-31 | 1.07 USD/EUR 10-K · filed 2023-02-27 | |
| 2021-12-31 | 1.13 USD/EUR 10-K · filed 2022-02-25 | |
| 2020-12-31 | 1.23 USD/EUR 10-K · filed 2021-03-01 | |
| 2020-09-30 | 1.17 USD/EUR 10-Q · filed 2020-10-27 | |
| 2020-06-30 | 1.12 USD/EUR 10-Q · filed 2020-07-30 | |
| 2020-03-31 | 1.10 USD/EUR 10-Q · filed 2020-04-29 | |
| 2019-12-31 | 1.12 USD/EUR 10-K · filed 2020-03-02 | |
| 2019-09-30 | 1.09 USD/EUR 10-Q · filed 2019-10-28 | |
| 2019-06-30 | 1.14 USD/EUR 10-Q · filed 2019-07-29 | |
| 2018-12-31 | 1.14 USD/EUR 10-Q · filed 2019-10-28 | 1.14 USD/EUR 10-Q · filed 2019-07-29 |
USD/CHF
| Period end | Foreign Currency Exchange Rate, Translation |
|---|---|
| 2025-12-31 | 1.26 USD/CHF 10-K · filed 2026-03-02 |
| 2024-12-31 | 1.10 USD/CHF 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |